Skip to main content

letter

. 2013 Apr 5;29(3):195. [Article in Spanish] doi: 10.1016/S0212-6567(02)70535-0

Anticonceptivos orales y esteatohepatitis no alcohólica

JC Estévez Muñoz ¹, P Carreño Freire ¹, JP Justel Pérez ¹, A Molina Cabañero ¹

PMCID: PMC7684113 PMID: 11879609

The content is available as a PDF (218.3 KB).

Xx

1.Reid A.E. Nonalcoholic steatohepatitis. Gastronterology. 2001;121:710–723. doi: 10.1053/gast.2001.27126. [DOI] [PubMed] [Google Scholar]
2.Caballería J., Parés A. Esteatohepatitis no alcohólica. Medicine. 2000;8:442–447. [Google Scholar]
3.Hannaford P.C., Kay C.R., Vessey M.P., Painter R., Mant J. Combined oral contraceptives and liver disease. Contraception. 1997;55:145–151. doi: 10.1016/s0010-7824(97)00023-1. [DOI] [PubMed] [Google Scholar]
4.Chitturi S., Farrell G.C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2001;21:27–41. doi: 10.1055/s-2001-12927. [DOI] [PubMed] [Google Scholar]
5.Giordiano N., Nardi P., Santacroce C., Geraci S., Gennari C. Acute hepatitis induced by cyproterone acetate. Ann Pharmcoter. 2001;35:1053–1055. doi: 10.1177/106002800103500902. [DOI] [PubMed] [Google Scholar]
6.Bruguera M. Lesiones hepáticas por fármacos. Medicine. 2000;8:448–452. [Google Scholar]

ACTIONS

RESOURCES